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Abstract: We present the findings of an early-stage primary mucinous sweat gland 
  adenocarcinoma in the lower eyelid of a Japanese patient. The patient was a 73-year-old man 
who had had a nodule on the left lower eyelid for two years. He was referred to our hospital with 
a diagnosis of a swollen chalazion. The clinical and histopathological records were reviewed 
and the mass was excised. Histopathological examination revealed a mucinous sweat gland 
adenocarcinoma. Postoperative magnetic resonance imaging and positron emission tomography 
excluded systemic metastases. After the histopathological findings, a complete surgical   excision 
of the margins of the adenocarcinoma was performed, with histopathological confirmation of 
negative margins. After the final histopathological examination, the patient was diagnosed with 
a primary mucinous sweat gland adenocarcinoma of the left eyelid. Six months after the surgery, 
no recurrence has been observed. Because the appearance of mucinous sweat gland adenocarci-
noma of the eyelid is quite variable, the final diagnosis can only be made by   histopathological 
examination. A complete surgical excision is recommended.
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Introduction
Primary mucinous sweat gland adenocarcinoma of the eyelid is very rare in Japan.1 
A search of PubMed yielded 25 articles describing 55 patients with mucinous sweat 
gland adenocarcinoma of the eyelid.1 Of the 55 patients, only two Asian cases (5.7%) 
were reported,1 and 28 (50.9%) were Caucasians.1 We present the findings in a Japanese 
patient with primary mucinous sweat gland adenocarcinoma of the left lower eyelid at 
an early stage and discuss the progression pattern of this adenocarcinoma.
Case report
A 73-year-old man noticed a swelling of the left lower eyelid two years earlier. 
Because the size of the nodule gradually increased, the patient was referred to Chiba 
  University Hospital for evaluation. He had systemic hypertension but no family 
  history of any ocular diseases. At 69 years of age, he had undergone polypectomy 
for colonic cancer.
At our first examination, an 8 mm × 10 mm painless, mobile nodule was palpable in 
the left eyelid. The mass resembled a benign granuloma or chalazion (Figure 1A).
We performed nodule excision with clinically visible margins. The tentative 
  diagnosis during the operation was a hemangioma and not a chalazion or benign 
granuloma. The nodule was horizontally extended and attached to the tarsal plate. Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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  Histopathology revealed floating clumps of cuboidal cells 
with focal duct formation in the abundant mucin lakes 
(Figure 2). Postoperative magnetic resonance imaging 
and positron emission tomography scanning excluded 
  systemic tumors. Thus, the final diagnosis of his tumor was 
a   primary mucinous sweat gland adenocarcinoma of the left 
lower   eyelid. Because of the histopathological diagnosis, 
we   performed a second operation to excise the margins 
of the tumor until the tissue was histologically confirmed 
to be negative. Six months after the second operation, no 
  recurrence or metastasis was found (Figure 1B).
Discussion
The prevalence of mucinous sweat gland adenocarcinoma of 
the eyelid seems to be lower in Asians than in the   Caucasian 
population.1 In many cases, the initial diagnosis was that 
the mass was benign, as in our case.1,2 Zhang et al reported 
six cases of mucinous eccrine adenocarcinoma of the 
eyelid.2 The initial clinical diagnosis in the different cases 
was papilloma, neoplasm, chalazion, pyogenic granuloma, 
hemangioma, and basal cell carcinoma.2 Thus, the clinical 
appearance of mucinous sweat gland carcinoma of the eyelid 
is very variable.
Mucinous sweat gland adenocarcinoma of the eyelid arises 
from an eccrine gland or apocrine gland.2 Histologically, the 
tumor in our patient was composed of floating clumps of 
carcinoma cells in a sea of mucin, but we could not determine 
the precise origin in our case. It is unlikely that the adenocar-
cinoma in our patient was a metastasis of colonic cancer from 
the histology suggesting mucinous sweat gland adenocarci-
noma and positron emission tomography findings indicating 
no recurrence of colonic cancer or systemic metastasis.
The progression pattern at the early stage of mucinous 
sweat gland adenocarcinoma of the eyelid is shown in 
Figure 3. In general, a sebaceous carcinoma is vertically 
extended in the eyelid at the initial stage. Thus, in many 
cases, the progression pattern could be differentiated from 
benign disorders, such as chalazion. However, a mucinous 
sweat gland adenocarcinoma is present on the surface of the 
eyelid and extends horizontally slowly onto the tarsal plate 
(Figure 3). Thus, the mucinous sweat gland adenocarcinoma 
of the eyelid is extremely difficult to differentiate from a 
malignant tumor at the initial stage. In some cases, malignant 
should probably be changed for benign. In fact, some patients 
have had a recurrence of tumor at the excised region, which 
was reported to be benign.3–5
In summary, we have reported a Japanese case of 
  primary mucinous sweat gland adenocarcinoma of the 
eyelid. Because of the difficulties in differentiating it from 
benign   disorders, histopathological examination should be 
performed. A   complete excision with histological confirma-
tion of negative surgical margins of resection is required to 
reduce the chances of a recurrence.
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Figure 1 Preoperative clinical appearance of the left lower eyelid mass (A) and 
postoperative clinical appearance of the left lower eyelid lesion (B). The mass was 
painless and mobile (A) and no recurrence had occurred six months after complete 
excision surgery (B).
Figure 2 Histopathological findings from the specimen. Floating clumps of cuboidal 
cells with focal duct formation in the abundant mucin lakes (arrows) indicate a sweat 
gland adenocarcinoma.
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Figure 3 scheme for the progression pattern of the sweat gland adenocarcinoma 
compared with sebaceous carcinoma of the eyelid. In general, a sebaceous carcinoma 
is  vertically  extended  in  the  eyelid  at  the  initial  stage.  However,  the  mucinous 
sweat gland adenocarcinoma is present on the surface of the eyelid and extends 
horizontally slowly onto the tarsal plate.Clinical Ophthalmology
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